Company intelligence / Profile preview

BioxCelleration

Palm Beach, Florida, United States

Ownership: Private
Development stage: Other

Overview

BioxCelleration is a biotechnology company specializing in advanced regenerative medicine and cellular therapies. The company focuses on the clinical application of mesenchymal stem cells (MSCs) and exosomes to treat a wide range of conditions, including autoimmune diseases, neurological disorders, and orthopedic injuries. BioxCelleration operates high-end treatment centers where they provide personalized regenerative protocols aimed at reducing inflammation and promoting tissue repair. Their services are designed to enhance longevity and improve the quality of life for patients with chronic or degenerative health issues.

Therapeutic areas: NeurologyRheumatologyImmunologyOther
Modalities: Stem cell therapyExosome-based therapy
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on BioxCelleration.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioxCelleration.

Explore the full profile